ReP USP - Resultado da busca

Artigo de periodico
Crosstalk between hnRNP K and SET in ATRA‐induced differentiation in acute promyelocytic leukemia (2021)
Padovani, Karina Stringhetta; Goto, Renata Nishida; Fugio, Lais Brigliadori; Garcia, Cristiana Bernadelli ; Alves, Vani Maria; Brassesco, Maria Sol ; Greene, Lewis Joel; Rego, Eduardo Magalhães; Leopoldino, Andréia Machado
Source: FEBS Open Bio. Unidades: FCFRP, FMRP, FFCLRP, FM
Subjects: LEUCEMIA, EXPRESSÃO GÊNICA, TRANSCRIÇÃO GÊNICA, CÉLULAS DA MEDULA ÓSSEA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PADOVANI, Karina Stringhetta et al. Crosstalk between hnRNP K and SET in ATRA‐induced differentiation in acute promyelocytic leukemia. FEBS Open Bio, v. 11, n. 7, p. 2019-2032, 2021Tradução . . Disponível em: https://doi.org/10.1002/2211-5463.13210. Acesso em: 12 nov. 2024.
APA
Padovani, K. S., Goto, R. N., Fugio, L. B., Garcia, C. B., Alves, V. M., Brassesco, M. S., et al. (2021). Crosstalk between hnRNP K and SET in ATRA‐induced differentiation in acute promyelocytic leukemia. FEBS Open Bio, 11( 7), 2019-2032. doi:10.1002/2211-5463.13210
NLM
Padovani KS, Goto RN, Fugio LB, Garcia CB, Alves VM, Brassesco MS, Greene LJ, Rego EM, Leopoldino AM. Crosstalk between hnRNP K and SET in ATRA‐induced differentiation in acute promyelocytic leukemia [Internet]. FEBS Open Bio. 2021 ; 11( 7): 2019-2032.[citado 2024 nov. 12 ] Available from: https://doi.org/10.1002/2211-5463.13210
Vancouver
Padovani KS, Goto RN, Fugio LB, Garcia CB, Alves VM, Brassesco MS, Greene LJ, Rego EM, Leopoldino AM. Crosstalk between hnRNP K and SET in ATRA‐induced differentiation in acute promyelocytic leukemia [Internet]. FEBS Open Bio. 2021 ; 11( 7): 2019-2032.[citado 2024 nov. 12 ] Available from: https://doi.org/10.1002/2211-5463.13210
Artigo de periodico
NTAL is associated with treatment outcome, cell proliferation and differentiation in acute promyelocytic leukemia (2020)
Thomé, Carolina Hassibe ; Ferreira, Germano Aguiar ; Martins, Diego Antonio Pereira ; Santos, Guilherme Augusto dos; Ortiz, César Alexander; Souza, Lucas Eduardo Botelho de ; Sobral, Lays Martins; Silva, Cleide Lúcia Araújo; Scheucher, Priscila Santos ; Gil, Cristiane Damas; Leopoldino, Andréia Machado ; Silveira, Douglas Rafaele Almeida ; Silva, Juan Luiz Coelho da ; Traina, Fabiola ; Koury, Luisa C.; Melo, Raul A. M.; Bittencourt, Rosane; Pagnano, Katia; Pasquini, Ricardo; Nunes, Elenaide C.; Fagundes, Evandro M.; Gloria, Ana Beatriz F.; kerbauy, Fábio Rodrigues; Chauffaille, Maria de Lourdes; Keating, Armand; Tallman, Martin S.; Ribeiro, Raul C.; Dillon, Richard; Ganser, Arnold; Löwenberg, Bob; Valk, Peter; Lo-Coco, Francesco; Sanz, Miguel A.; Berliner, Nancy; Faça, Vitor Marcel ; Rego, Eduardo Magalhaes
Source: Scientific Reports. Unidades: FMRP, FCFRP, FM
Subjects: PROTEÍNAS, TRANSDUÇÃO DE SINAL CELULAR, QUIMIOTERAPIA, ANTINEOPLÁSICOS, MEDULA ÓSSEA, DIFERENCIAÇÃO CELULAR, SOBREVIVÊNCIA CELULAR, LEUCEMIA, FARMACOTERAPIA, ANÁLISE DE SOBREVIVÊNCIA, ESTUDOS RETROSPECTIVOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
THOMÉ, Carolina Hassibe et al. NTAL is associated with treatment outcome, cell proliferation and differentiation in acute promyelocytic leukemia. Scientific Reports, v. 10, n. 1, 2020Tradução . . Disponível em: https://doi.org/10.1038/s41598-020-66223-2. Acesso em: 12 nov. 2024.
APA
Thomé, C. H., Ferreira, G. A., Martins, D. A. P., Santos, G. A. dos, Ortiz, C. A., Souza, L. E. B. de, et al. (2020). NTAL is associated with treatment outcome, cell proliferation and differentiation in acute promyelocytic leukemia. Scientific Reports, 10( 1). doi:10.1038/s41598-020-66223-2
NLM
Thomé CH, Ferreira GA, Martins DAP, Santos GA dos, Ortiz CA, Souza LEB de, Sobral LM, Silva CLA, Scheucher PS, Gil CD, Leopoldino AM, Silveira DRA, Silva JLC da, Traina F, Koury LC, Melo RAM, Bittencourt R, Pagnano K, Pasquini R, Nunes EC, Fagundes EM, Gloria ABF, kerbauy FR, Chauffaille M de L, Keating A, Tallman MS, Ribeiro RC, Dillon R, Ganser A, Löwenberg B, Valk P, Lo-Coco F, Sanz MA, Berliner N, Faça VM, Rego EM. NTAL is associated with treatment outcome, cell proliferation and differentiation in acute promyelocytic leukemia [Internet]. Scientific Reports. 2020 ; 10( 1):[citado 2024 nov. 12 ] Available from: https://doi.org/10.1038/s41598-020-66223-2
Vancouver
Thomé CH, Ferreira GA, Martins DAP, Santos GA dos, Ortiz CA, Souza LEB de, Sobral LM, Silva CLA, Scheucher PS, Gil CD, Leopoldino AM, Silveira DRA, Silva JLC da, Traina F, Koury LC, Melo RAM, Bittencourt R, Pagnano K, Pasquini R, Nunes EC, Fagundes EM, Gloria ABF, kerbauy FR, Chauffaille M de L, Keating A, Tallman MS, Ribeiro RC, Dillon R, Ganser A, Löwenberg B, Valk P, Lo-Coco F, Sanz MA, Berliner N, Faça VM, Rego EM. NTAL is associated with treatment outcome, cell proliferation and differentiation in acute promyelocytic leukemia [Internet]. Scientific Reports. 2020 ; 10( 1):[citado 2024 nov. 12 ] Available from: https://doi.org/10.1038/s41598-020-66223-2
Artigo de periodico
Metformin exerts multitarget antileukemia activity in JAK2V617F-positive myeloproliferative neoplasms (2018)
Machado Neto, João Agostinho ; Fenerich, Bruna Alves; Ribeiro, Renata Scopim; Eide, Christopher A; Silva, Juan Luiz Coelho da; Dechandt, Carlos Roberto Porto; Fernandes, Jaqueline Cristina; Alves, Ana Paula Nunes Rodrigues; Scheucher, Priscila Santos; Simões, Belinda Pinto; Alberici, Luciane Carla; Pontes, Lorena Lôbo de Figueiredo; Tognon, Cristina E; Druker, Brian J; Rego, Eduardo Magalhães; Traina, Fabíola
Source: Cell Death & Disease. Unidades: ICB, FMRP, FCFRP, FM
Subjects: METFORMINA, PROLIFERAÇÃO CELULAR, APOPTOSE, MUTAÇÃO GENÉTICA, LEUCEMIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MACHADO NETO, João Agostinho et al. Metformin exerts multitarget antileukemia activity in JAK2V617F-positive myeloproliferative neoplasms. Cell Death & Disease, v. 9, n. 3, p. 16 , 2018Tradução . . Disponível em: https://doi.org/10.1038/s41419-017-0256-4. Acesso em: 12 nov. 2024.
APA
Machado Neto, J. A., Fenerich, B. A., Ribeiro, R. S., Eide, C. A., Silva, J. L. C. da, Dechandt, C. R. P., et al. (2018). Metformin exerts multitarget antileukemia activity in JAK2V617F-positive myeloproliferative neoplasms. Cell Death & Disease, 9( 3), 16 . doi:10.1038/s41419-017-0256-4
NLM
Machado Neto JA, Fenerich BA, Ribeiro RS, Eide CA, Silva JLC da, Dechandt CRP, Fernandes JC, Alves APNR, Scheucher PS, Simões BP, Alberici LC, Pontes LL de F, Tognon CE, Druker BJ, Rego EM, Traina F. Metformin exerts multitarget antileukemia activity in JAK2V617F-positive myeloproliferative neoplasms [Internet]. Cell Death & Disease. 2018 ; 9( 3): 16 .[citado 2024 nov. 12 ] Available from: https://doi.org/10.1038/s41419-017-0256-4
Vancouver
Machado Neto JA, Fenerich BA, Ribeiro RS, Eide CA, Silva JLC da, Dechandt CRP, Fernandes JC, Alves APNR, Scheucher PS, Simões BP, Alberici LC, Pontes LL de F, Tognon CE, Druker BJ, Rego EM, Traina F. Metformin exerts multitarget antileukemia activity in JAK2V617F-positive myeloproliferative neoplasms [Internet]. Cell Death & Disease. 2018 ; 9( 3): 16 .[citado 2024 nov. 12 ] Available from: https://doi.org/10.1038/s41419-017-0256-4

USP Schools

ReP

Filtros

Departament

Authors

USP affiliated authors

Subjects

Indexado em

Non normalized affiliation

Countries of institutions of collaboration